Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AVE LAUNCHES MICRO STENT II, SLATES GFX SHIPMENTS FOR MARCH FOLLOWING DEC. 23 FDA APPROVAL; RAPID EXCHANGE DELIVERY SYSTEM IN CLINICALS

This article was originally published in The Gray Sheet

Executive Summary

Arterial Vascular Engineering is planning to launch its Micro Stent II and gfx coronary stent systems in two phases following premarket approval application clearance by FDA on Dec. 23, the company says. Shipments of the Micro Stent II will commence immediately while roll out of the gfx is scheduled for March following inventory ramp up.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009332

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel